Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E W Ehrich

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Journal of Rheumatology|January 5, 2002
Precision of composite measures of osteoarthritis efficacy in comparison to that of individual endpointsJ A Bolognese, E W Ehrich, T J Schnitzer
Osteoarthritis and Cartilage|June 20, 2003
Response relationship of VAS and Likert scales in osteoarthritis efficacy measurementJ A Bolognese, T J Schnitzer, E W Ehrich
Archives of Dermatology|June 1, 1992
Association of granuloma annulare with sarcoidosisE W Ehrich, J L McGuire, Y H Kim
Annals of Internal Medicine|June 15, 1990
A late relapse of Wegener granulomatosisE W Ehrich, J L McGuire, H O McDevitt
The American Journal of Managed Care|July 7, 2001
Effect of rofecoxib therapy on measures of health-related quality of life in patients with osteoarthritisE W Ehrich, J A Bolognese, D J Watson, et al.
Annual Review of Immunology|January 1, 1992
Molecular components of T-cell recognitionJ L Jorgensen, P A Reay, E W Ehrich, et al.
The Journal of Rheumatology|November 16, 2001
Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factorsL M Detora, D Krupa, J Bolognese, et al.
The Journal of Rheumatology|November 28, 2000
Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritisE W Ehrich, G M Davies, D J Watson, et al.
The Journal of Experimental Medicine|August 1, 1993
T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigenE W Ehrich, B Devaux, E P Rock, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|February 1, 1996
A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitorsC Brideau, S Kargman, S Liu, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Journal of Rheumatology|January 5, 2002
Precision of composite measures of osteoarthritis efficacy in comparison to that of individual endpointsJ A Bolognese, E W Ehrich, T J Schnitzer
Osteoarthritis and Cartilage|June 20, 2003
Response relationship of VAS and Likert scales in osteoarthritis efficacy measurementJ A Bolognese, T J Schnitzer, E W Ehrich
Archives of Dermatology|June 1, 1992
Association of granuloma annulare with sarcoidosisE W Ehrich, J L McGuire, Y H Kim
Annals of Internal Medicine|June 15, 1990
A late relapse of Wegener granulomatosisE W Ehrich, J L McGuire, H O McDevitt
The American Journal of Managed Care|July 7, 2001
Effect of rofecoxib therapy on measures of health-related quality of life in patients with osteoarthritisE W Ehrich, J A Bolognese, D J Watson, et al.
Annual Review of Immunology|January 1, 1992
Molecular components of T-cell recognitionJ L Jorgensen, P A Reay, E W Ehrich, et al.
The Journal of Rheumatology|November 16, 2001
Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factorsL M Detora, D Krupa, J Bolognese, et al.
The Journal of Rheumatology|November 28, 2000
Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritisE W Ehrich, G M Davies, D J Watson, et al.
The Journal of Experimental Medicine|August 1, 1993
T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigenE W Ehrich, B Devaux, E P Rock, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|February 1, 1996
A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitorsC Brideau, S Kargman, S Liu, et al.
Pageof 2